Andere Kunden interessierten sich auch für
![Clinical Trials in Surgical Oncology, An Issue of Surgical Oncology Clinics of North America]( "Clinical Trials in Surgical Oncology, An Issue of Surgical Oncology Clinics of North America")
Clinical Trials in Surgical Oncology, An Issue of Surgical Oncology Clinics of North America65,99 €![Investigative Electrocardiography in Epidemiological Studies and Clinical Trials]( "Investigative Electrocardiography in Epidemiological Studies and Clinical Trials")
Investigative Electrocardiography in Epidemiological Studies and Clinical Trials81,99 €![Clinical Drug Trials and Tribulations, Revised and Expanded]( "Clinical Drug Trials and Tribulations, Revised and Expanded")
Clinical Drug Trials and Tribulations, Revised and Expanded254,99 €![Clinical Trials in Rheumatology]( "Clinical Trials in Rheumatology")
Clinical Trials in Rheumatology218,99 €![Clinical Trials in Surgical Oncology, An Issue of Surgical Oncology Clinics of North America]( "Clinical Trials in Surgical Oncology, An Issue of Surgical Oncology Clinics of North America")
Clinical Trials in Surgical Oncology, An Issue of Surgical Oncology Clinics of North America69,99 €![Understanding Evidence-Based Rheumatology]( "Understanding Evidence-Based Rheumatology")
Understanding Evidence-Based Rheumatology88,99 €![The Unmet Objective of Health Financing in India. Affordable Health Care for All]( "The Unmet Objective of Health Financing in India. Affordable Health Care for All")
The Unmet Objective of Health Financing in India. Affordable Health Care for All42,95 €
Master's Thesis from the year 2013 in the subject Medicine - Hospital Environment, Clinical Medicine, Walden University, course: Clinical Research and Administration- General concentration, language: English, abstract: India and China have been identified by pharmaceutical companies as the future markets thatwould support drug research and development in a cost efficient manner. This has becomenecessary as resources to conduct clinical studies dwindle, coupled with the fact thatpharmaceutical industries are under pressure to deliver quality medicine, on time, to the public.Exploring and examining India and China's potential in a stepwise fashion provides theopportunity to dissect the good, the bad and the ugly of globalization in a comparative approach.This paper will cover areas like ethics in the conduct of studies, good clinical practice (GCP),economic realities, ICH influence, intellectual property security and the role of government inglobal clinical trial.